Effect of Piboserod, a 5-HT4 Serotonin Receptor Antagonist, on Left Ventricular Function in Patients with Symptomatic Heart Failure

Although patients with chronic HF had a small but significant improvement in LVEF when treated with piboserod for 24 weeks, the result was not reflected in significant changes in other efficacy parameters, and its clinical relevance remains uncertain.